Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Creative Medical Technology Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Creative Medical Technology Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Warbington Timothy | President & CEO | 1,034,904Indirect | Sep 25, 2026 | 1 |
| Creative Acquisition Corp. | Director | 1,034,904Indirect | Sep 25, 2026 | 1 |
| Finger Michael H. | Director | 351 | Feb 20, 2025 | 0 |
| Dickerson Donald | CFO & Sr. VP | – | Feb 11, 2022 | 0 |
| Ichim Thomas | Director | 4,529,522 | Jul 22, 2021 | 0 |
| Patel Amit Nilkanth | Director | – | Jul 16, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 (view filing) | Feb 18-19 | 2 days | Finger Michael H.Director | SSale | −1.50K | $5.38 | −$8.06K | −81.0%351 after | 2 lots |
| Jun 29, 2023 (view filing) | Jun 27-28 | 2 days | Warbington TimothyPresident & CEO | PPurchase | +1.00K | $4.42 | +$4.42K | +8.9%12.2K after | 4 lots |
| Nov 23, 2022 (view filing)9:09 AM ET | Nov 21-22 | 2 days | Warbington TimothyPresident & CEO | PPurchase | +25.0K | $0.3945 | +$9.86K | +28.7%112.1K after | 4 lots |
| Sep 29, 2022 (view filing) | Sep 27 | 2 days | Finger Michael H.Director | PPurchase | +2.00K | $0.50 | +$1.00K | +12.1%18.5K after | |
| Sep 28, 2022 (view filing) | Sep 27 | 1 day | Warbington TimothyPresident & CEO | PPurchase | +20.0K | $0.50 | +$10.0K | +29.8%87.1K after | |
| Sep 22, 2022 (view filing) | Sep 21-22 | 1 day | Warbington TimothyPresident & CEO | PPurchase | +42.0K | $0.5935 | +$24.9K | +167.4%67.1K after | 5 lots |
| Jun 14, 2022 (view filing) | Jun 14 | Same day | Finger Michael H.Director | PPurchase | +10.0K | $0.70 | +$7.00K | +153.8%16.5K after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Warbington TimothyPresident & CEO | PPurchase | +25.0K | $0.914 | +$22.9K | +28,735.6%25.1K after | 3 lots |
| May 20, 2022 (view filing) | May 20 | Same day | Finger Michael H.Director | PPurchase | +6.50K | $1.50 | +$9.75K | +325,000.0%6.50K after | |
| Jul 22, 2021 (view filing)8:54 PM ET | Jul 20-22 | 2 days | Ichim ThomasDirector | SSale | −4.35M | $0.0304 | −$132.4K | −49.0%4.53M after | 3 lots |